The FDA has granted Regenerative Medicine Advanced Therapy designation to Enlivex’s experimental immunotherapy Allocetra for age-related knee osteoarthritis, Investing.com has learned.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results